Literature DB >> 1547921

Human monocyte interactions with non-enzymatically glycated collagen.

M Z Gilcrease1, R L Hoover.   

Abstract

We have previously shown that receptors for advanced glycation end products are expressed on activated human monocytes. We now report that activated human monocytes exhibit increased adhesion to non-enzymatically glycated collagen substrates (+32% +/- 1, p less than 0.001), and the increased adhesion can be competitively inhibited with non-enzymatically glycated albumin. Non-activated monocytes, which do not express receptors for advanced glycation end products, exhibit decreased adhesion (-16% +/- 1, p less than 0.001). Similar results were observed with substrates of fibronectin and endothelial cell matrix proteins. As the presence of glycation adducts on collagen interferes with the normal binding of monocytes/macrophages, one possible role for advanced glycation adduct receptors on activated monocytes is to counterbalance such decreased adherence. Overcompensation for long periods of time may lead to pathological changes. Additionally, such receptors may play a role in monocyte-mediated remodelling of glycated matrix proteins, as we have observed increased degradation of non-enzymatically glycated collagen substrates by activated human monocytes at 2 h (+52% +/- 11, p = 0.01), 3 h (+49% +/- 10, 10, p = 0.01), and 4 h (+36% +/- 6, p less than 0.01) after adding activated monocytes to 125I-labelled substrates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547921     DOI: 10.1007/bf00402549

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

Review 1.  Protein glycosylation and the pathogenesis of atherosclerosis.

Authors:  A Cerami; H Vlassara; M Brownlee
Journal:  Metabolism       Date:  1985-12       Impact factor: 8.694

2.  Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.

Authors:  V M Monnier; A Cerami
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

Review 3.  Non-enzymatic glycosylation and browning of proteins in diabetes.

Authors:  V M Monnier; A Cerami
Journal:  Clin Endocrinol Metab       Date:  1982-07

4.  Non enzymatic glycosylation of proteins.

Authors:  K H Winterhalter
Journal:  Prog Clin Biol Res       Date:  1985

Review 5.  Leukocyte-endothelial interactions.

Authors:  J M Harlan
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

6.  Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.

Authors:  H Vlassara; L Moldawer; B Chan
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products.

Authors:  S Radoff; H Vlassara; A Cerami
Journal:  Arch Biochem Biophys       Date:  1988-06       Impact factor: 4.013

8.  Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine.

Authors:  K Nicholls; T E Mandel
Journal:  Lab Invest       Date:  1989-04       Impact factor: 5.662

9.  Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo.

Authors:  H Vlassara; M Brownlee; A Cerami
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

10.  Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.

Authors:  H Vlassara; M Brownlee; A Cerami
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  4 in total

1.  Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

Authors:  B H Wolffenbuttel; C M Boulanger; F R Crijns; M S Huijberts; P Poitevin; G N Swennen; S Vasan; J J Egan; P Ulrich; A Cerami; B I Lévy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  RAGE mRNA expression in the diabetic mouse kidney.

Authors:  F N Ziyadeh; M P Cohen; J Guo; Y Jin
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

3.  In vitro glycoxidation alters the interactions between collagens and human polymorphonuclear leucocytes.

Authors:  J C Monboisse; L Rittie; H Lamfarraj; R Garnotel; P Gillery
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

4.  Effect of glycated collagen on proliferation of human smooth muscle cells in vitro.

Authors:  K Iino; M Yoshinari; M Yamamoto; K Kaku; Y Doi; K Ichikawa; M Iwase; M Fujishima
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.